Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde, NN NN

1318 Citationer (Scopus)

Abstract

Udgivelsesdato: 2009-Jul-4
OriginalsprogEngelsk
TidsskriftLancet
Vol/bind374
Udgave nummer9683
Sider (fra-til)39-47
Antal sider8
ISSN1474-547X
DOI
StatusUdgivet - 2009

Fingeraftryk

Dyk ned i forskningsemnerne om 'Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)'. Sammen danner de et unikt fingeraftryk.

Citationsformater